Podcast Episodes
Back to SearchAre Oral SERDs About to Transform Breast Cancer Care?
Episode 14
The development of oral selective estrogen receptor degraders (SERDs) represents substantial progress for patients with metastatic breast cancer who …
8 months, 2 weeks ago
Game-Changers and Paradigm Shifts: ASCO 2025 Data Shake Up Breast Cancer Care
Episode 12
From a “game-changer” in triple-negative disease to broader paradigm shifts and practice changes, the 2025 American Society of Clinical Oncology (ASC…
8 months, 2 weeks ago
Practice-Changing Data in Colorectal Cancer Lead to Broader Questions in Oncology
Episode 11
Results from the phase 3 ATOMIC trial are practice changing for colorectal cancer care and raise broader questions about immunotherapy use in patient…
8 months, 3 weeks ago
Oncologist Faculty Burnout Caused by “Unrealistic” Expectations, Says ASCO CEO
Episode 13
“An increasingly unrealistic set of performance expectations” is putting a strain on oncologist faculty members, says Clifford Hudis, MD, CEO of the …
8 months, 3 weeks ago
After Years of Inactivity, “Dizzying” Changes Hit Bladder Cancer Care
Episode 10
“For the first 15 years of my career, we had nothing new” in bladder cancer care, said Jonathan E. Rosenberg, MD, chief of the genitourinary oncology…
8 months, 3 weeks ago
Practice Changing or “Practice Confounding”? Pivotal Breast Cancer Data Raise Big Questions
Episode 9
Findings from the SERENA-6 trial, which examined switching therapies in patients with breast cancer ahead of disease progression, made headlines duri…
8 months, 4 weeks ago
NCCN CEO Discusses Guideline Updates, Other Key Initiatives
Episode 8
From digitizing its guidelines to potential embedding them in EMRs, the National Comprehensive Cancer Network (NCCN) is working to “make the workflo…
9 months ago
Former National Cancer Institute Director Discusses the Future of Cancer Care
Episode 5
“Is it time to do something big and different? That’s always a good question to ask,” said W. Kimryn Rathmell, MD, PhD, MMHC, the immediate former di…
9 months, 1 week ago
Game-Changing Blood Cancer News at ASCO 2025: Rusfertide Shows Strong Benefit in Polycythemia Vera
Episode 4
A late-breaking abstract presented at the 2025 American Society of Clinical Oncology Annual Meeting (LBA3) showed that rusfertide significantly incre…
9 months, 1 week ago
Getting Americans to Support Cancer Research May Take a New Message, Oncology Leader Says
Episode 3
When it comes to building support for cancer research in the current environment, “the message that we have had in our field is a good one. But we ma…
9 months, 2 weeks ago